Windtree Therapeutics

Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a leading biopharmaceutical company, delivered its financial results for the fourth quarter and fiscal year, that ended December 31, 2023.

Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023 Read More

EPAM Systems, Inc.

EPAM Systems Elevates to Platinum Partner Status with commercetools, Leading Composable Commerce Transformation

NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM), a leading global provider of digital platform engineering and software development services, has been awarded Platinum Partner status by commercetools. This prestigious …

EPAM Systems Elevates to Platinum Partner Status with commercetools, Leading Composable Commerce Transformation Read More